Carbon monoxide releasing molecule-A1 improves nonalcoholic steatohepatitis via Nrf2 activation mediated improvement in oxidative stress and mitochondrial function. Here, NFE2L2 is linked to metabolic dysfunction-associated steatohepatitis.